Muller AE - Search Results

1

MIC-based dose adjustment: facts and fables.

Mouton JW, Muller AE, Canton R, Giske CG, Kahlmeter G, Turnidge J. Mouton JW, et al. Among authors: muller ae. J Antimicrob Chemother. 2018 Mar 1;73(3):564-568. doi: 10.1093/jac/dkx427. J Antimicrob Chemother. 2018. PMID: 29216348

2

Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.

Muller AE, DeJongh J, Bult Y, Goessens WH, Mouton JW, Danhof M, van den Anker JN. Muller AE, et al. Antimicrob Agents Chemother. 2007 Oct;51(10):3720-5. doi: 10.1128/AAC.00318-07. Epub 2007 Jul 23. Antimicrob Agents Chemother. 2007. PMID: 17646418 Free PMC article.

3

Amoxicillin pharmacokinetics in pregnant women with preterm premature rupture of the membranes.

Muller AE, DeJongh J, Oostvogel PM, Voskuyl RA, Dörr PJ, Danhof M, Mouton JW. Muller AE, et al. Am J Obstet Gynecol. 2008 Jan;198(1):108.e1-6. doi: 10.1016/j.ajog.2007.05.018. Epub 2007 Dec 3. Am J Obstet Gynecol. 2008. PMID: 18061131 Clinical Trial.

4

The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women.

Muller AE, Dörr PJ, Mouton JW, De Jongh J, Oostvogel PM, Steegers EA, Voskuyl RA, Danhof M. Muller AE, et al. Br J Clin Pharmacol. 2008 Dec;66(6):866-74. doi: 10.1111/j.1365-2125.2008.03292.x. Br J Clin Pharmacol. 2008. PMID: 19032729 Free PMC article.

5

Pharmacokinetics of amoxicillin in maternal, umbilical cord, and neonatal sera.

Muller AE, Oostvogel PM, DeJongh J, Mouton JW, Steegers EA, Dörr PJ, Danhof M, Voskuyl RA. Muller AE, et al. Antimicrob Agents Chemother. 2009 Apr;53(4):1574-80. doi: 10.1128/AAC.00119-08. Epub 2009 Jan 21. Antimicrob Agents Chemother. 2009. PMID: 19164154 Free PMC article.

6

Pharmacokinetics of clindamycin in pregnant women in the peripartum period.

Muller AE, Mouton JW, Oostvogel PM, Dörr PJ, Voskuyl RA, DeJongh J, Steegers EA, Danhof M. Muller AE, et al. Antimicrob Agents Chemother. 2010 May;54(5):2175-81. doi: 10.1128/AAC.01017-09. Epub 2010 Feb 22. Antimicrob Agents Chemother. 2010. PMID: 20176904 Free PMC article. Clinical Trial.

7

Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia.

Muller AE, Punt N, Mouton JW. Muller AE, et al. J Antimicrob Chemother. 2013 Apr;68(4):900-6. doi: 10.1093/jac/dks468. Epub 2012 Nov 28. J Antimicrob Chemother. 2013. PMID: 23190766

8

Monte Carlo simulations based on phase 1 studies predict target attainment of ceftobiprole in nosocomial pneumonia patients: a validation study.

Muller AE, Schmitt-Hoffmann AH, Punt N, Mouton JW. Muller AE, et al. Antimicrob Agents Chemother. 2013 May;57(5):2047-53. doi: 10.1128/AAC.02292-12. Epub 2013 Feb 12. Antimicrob Agents Chemother. 2013. PMID: 23403430 Free PMC article.

9

Exposure to ceftobiprole is associated with microbiological eradication and clinical cure in patients with nosocomial pneumonia.

Muller AE, Punt N, Mouton JW. Muller AE, et al. Antimicrob Agents Chemother. 2014 May;58(5):2512-9. doi: 10.1128/AAC.02611-13. Epub 2014 Feb 10. Antimicrob Agents Chemother. 2014. PMID: 24514085 Free PMC article. Clinical Trial.

10

Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration.

Laterre PF, Wittebole X, Van de Velde S, Muller AE, Mouton JW, Carryn S, Tulkens PM, Dugernier T. Laterre PF, et al. Among authors: muller ae. J Antimicrob Chemother. 2015 Mar;70(3):891-8. doi: 10.1093/jac/dku465. Epub 2014 Nov 27. J Antimicrob Chemother. 2015. PMID: 25433006 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page